Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Propylthiouracil: clinical overview of its efficacy and its side effects more than 50 years after the introduction of its use in thyrostatic treatment.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2009
Same author

Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2008
Same author

Heat shock protein 70 (Hsp70) subtype expression in neuroendocrine tissue and identification of a neuroendocrine tumour-specific Hsp70 truncation.

Endocrine-related cancer·2004
Same author

Legal augmentation of iodine content in table salt from 10 to 20 mg KI/kg: documented effects a decade later.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2003
Same author

Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?

Clinical and experimental immunology·2003
Same author

[Diagnosis and therapy of Graves' ophthalmopathy--consensus guidelines].

Acta medica Austriaca·2002

Related Experiment Video

Updated: Jul 13, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

[Possible consequences of subclinical hypothyroidism].

M Weissel1

  • 1Allgemeinstation, Univ.-Klinik für Innere Medizin III, Währinger Gürtel 18-20, A-1090 Wien. michael.weissel@univie.ac.at

Acta Medica Austriaca
|January 9, 2004
PubMed
Summary

Subclinical hypothyroidism, marked by high thyroid-stimulating hormone (TSH) with normal thyroid hormones, doesn't always indicate thyroid failure. Treatment decisions for symptoms depend on TSH levels and potential risks.

More Related Videos

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function
04:05

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

Related Experiment Videos

Last Updated: Jul 13, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function
04:05

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

Area of Science:

  • Endocrinology
  • Thyroidology

Context:

  • Subclinical hypothyroidism (SCH) is characterized by elevated TSH with normal free T4 and T3.
  • Uncertainties persist regarding SCH diagnosis, progression, symptomatology, and treatment efficacy.

Purpose:

  • To review and address unresolved questions surrounding subclinical hypothyroidism.
  • To clarify the implications of elevated TSH, risk of progression, symptom presence, and L-Thyroxine treatment effectiveness in SCH.

Summary:

  • Elevated TSH with normal free T4 doesn't definitively mean thyroid failure.
  • High-risk individuals for overt hypothyroidism include those with positive thyroid antibodies and TSH > 10 mU/l.
  • Symptoms vary widely, with questionable clinical significance for some; cardiovascular symptoms may improve with L-Thyroxine, but lipid changes often do not.

Impact:

  • TSH and free T4 screening is recommended for elderly women due to SCH prevalence (~20%).
  • L-Thyroxine treatment for SCH symptoms is advised cautiously, primarily for TSH > 10 mU/l, to prevent overdosage and atrial fibrillation.